MINIMUM bio
MINIMUM bio is dedicated to improving drug discovery processes by providing a versatile, high throughput platform based on phage display technology. Their mission is to rapidly identify proteins that bind to bioactive molecules, enabling the development of new therapeutic targets, drug modalities, and safer pharmaceuticals. They aim to reduce the time and cost of preclinical R&D and discover new drug modalities for more effective and safer drugs for everyone.
Industries
Nr. of Employees
small (1-50)
MINIMUM bio
Sydney, New South Wales, Australia, Oceania
Products
Phage-display based target identification platform
A platform that constructs and screens phage-displayed protein libraries derived from cellular transcriptomes to identify binding partners of small molecules, biologics and molecular glues, with sequencing-based readout.
Phage-display based target identification platform
A platform that constructs and screens phage-displayed protein libraries derived from cellular transcriptomes to identify binding partners of small molecules, biologics and molecular glues, with sequencing-based readout.
Services
Contract or collaborative services to identify cellular protein targets and off-targets of bioactive compounds by screening transcriptome-derived phage libraries and sequencing selected binders.
In-house R&D and partnered discovery programs to identify non-degrader molecular glues and their target/bait proteins using iterative phage-display screening.
Contract or collaborative services to identify cellular protein targets and off-targets of bioactive compounds by screening transcriptome-derived phage libraries and sequencing selected binders.
In-house R&D and partnered discovery programs to identify non-degrader molecular glues and their target/bait proteins using iterative phage-display screening.
Expertise Areas
- Drug target identification
- Phage display and library engineering
- Chemical proteomics
- Molecular glue discovery
Key Technologies
- Phage display
- cDNA (transcriptome) library display
- Phage biopanning (iterative affinity selection)
- Sequencing-based readout of selected libraries
News & Updates
Research Scientist – Molecular Biology at MINIMUM bio Pty Ltd, focusing on drug target discovery and new drug modalities.
This is a test post for the MINIMUM bio blog.
Research Scientist – Molecular Biology at MINIMUM bio Pty Ltd, focusing on drug target discovery and new drug modalities.
This is a test post for the MINIMUM bio blog.